Brief: NUZ-001 Shows Promise In Zebrafish Model Of Huntington's Disease
16/06/2025 12:43
June 16 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: NUZ-001 SHOWS PROMISE IN ZEBRAFISH MODEL OF HUNTINGTON'S DISEASE NEURIZON THERAPEUTICS LTD - TO INITIATE VALIDATION STUDIES IN MAMMALIAN MODELS OF HUNTINGTON'S DISEASE Source text: ID:nPn5622mYa Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO